右旋糖苷铁注射剂治疗缺铁性贫血
Journal of Harbin Medical University(2006)
Abstract
缺铁性贫血的治疗多年来一直以口服铁剂为主,但对胃肠道疾患及胃切除术后患者,口服铁剂难以奏效.当铁储备减小、血清铁蛋白小于12ng/ml,铁转移到骨髓红系受损,转铁饱和度<16%时,考虑有绝对性铁缺乏,因此静脉注射铁剂日趋引起重视.目前美国已批准的两种静脉注射的右旋糖苷铁为InFed(商品名为"科莫非")和Dexferrum.本文报道近2年应用科莫非治疗缺铁性贫血(IDA)33例,现报告如下.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined